4:20pm PDT - October 8th, 2022

About 8 months away from the agent’s PDUFA date, data from a post-hoc analysis of SOLOIST-WHF is providing insight into the effects of sotagliflozin on first and subsequent heart failure-related events among people admitted for worsening heart failure. https://t.co/y7HPQTnODb

0 retweets   0 likes  - Practical Cardiology (@practicalcardio)